Header Logo

Connection

Amanda Krause to Humans

This is a "connection" page, showing publications Amanda Krause has written about Humans.
Connection Strength

1,543
  1. Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease. J Huntingtons Dis. 2025 Feb; 14(1):103-108.
    View in: PubMed
    Score: 0,072
  2. Huntington disease-like 2: insight into neurodegeneration from an African disease. Nat Rev Neurol. 2024 01; 20(1):36-49.
    View in: PubMed
    Score: 0,068
  3. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation. Mol Genet Genomic Med. 2020 08; 8(8):e1351.
    View in: PubMed
    Score: 0,053
  4. A comparison between the neurocognitive profile of Huntington Disease-Like 2 and Huntington Disease: Exploring the presence of double dissociations. Appl Neuropsychol Adult. 2022 Mar-Apr; 29(2):223-233.
    View in: PubMed
    Score: 0,052
  5. The neuropsychological deficits and dissociations in Huntington Disease-Like 2: A series of case-control studies. Neuropsychologia. 2020 01; 136:107238.
    View in: PubMed
    Score: 0,051
  6. Role of family history and clinical screening in the identification of families with idiopathic dilated cardiomyopathy in Johannesburg, South Africa. S Afr Med J. 2019 Aug 28; 109(9):673-678.
    View in: PubMed
    Score: 0,050
  7. Review of 10 years of preimplantation genetic diagnosis in South Africa: implications for a low-to-middle-income country. J Assist Reprod Genet. 2019 Sep; 36(9):1909-1916.
    View in: PubMed
    Score: 0,050
  8. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome. Fam Cancer. 2018 10; 17(4):607-613.
    View in: PubMed
    Score: 0,047
  9. Common and Founder Mutations for Monogenic Traits in Sub-Saharan African Populations. Annu Rev Genomics Hum Genet. 2018 08 31; 19:149-175.
    View in: PubMed
    Score: 0,047
  10. Fanconi anaemia in South Africa: Past, present and future. S Afr Med J. 2018 Apr 25; 108(5):393-398.
    View in: PubMed
    Score: 0,046
  11. A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci. J Neurol Sci. 2018 07 15; 390:200-204.
    View in: PubMed
    Score: 0,046
  12. Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's Disease. Tremor Other Hyperkinet Mov (N Y). 2017; 7:512.
    View in: PubMed
    Score: 0,045
  13. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia. Fam Cancer. 2017 07; 16(3):441-446.
    View in: PubMed
    Score: 0,043
  14. A Systematic Review of the Huntington Disease-Like 2 Phenotype. J Huntingtons Dis. 2017; 6(1):37-46.
    View in: PubMed
    Score: 0,042
  15. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet B Neuropsychiatr Genet. 2015 Oct; 168(7):573-85.
    View in: PubMed
    Score: 0,038
  16. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia. Blood Cells Mol Dis. 2015 Mar; 54(3):270-4.
    View in: PubMed
    Score: 0,036
  17. Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients. Haemophilia. 2014 Sep; 20(5):687-92.
    View in: PubMed
    Score: 0,035
  18. Phenotypic consequences in black South African Fanconi anemia patients homozygous for a founder mutation. Genet Med. 2014 May; 16(5):400-6.
    View in: PubMed
    Score: 0,033
  19. Human genetics in Johannesburg, South Africa: past, present and future. S Afr Med J. 2013 Oct 11; 103(12 Suppl 1):957-61.
    View in: PubMed
    Score: 0,033
  20. Fanconi anaemia in black South African patients heterozygous for the FANCG c.637-643delTACCGCC founder mutation. S Afr Med J. 2013 Oct 11; 103(12 Suppl 1):970-3.
    View in: PubMed
    Score: 0,033
  21. Testing for haemoglobinopathies in Johannesburg, South Africa: a 30-year review. S Afr Med J. 2013 Oct 11; 103(12 Suppl 1):989-93.
    View in: PubMed
    Score: 0,033
  22. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review. S Afr Med J. 2013 Oct 11; 103(12 Suppl 1):994-8.
    View in: PubMed
    Score: 0,033
  23. Genetic testing for Duchenne/Becker muscular dystrophy in Johannesburg, South Africa. S Afr Med J. 2013 Oct 10; 103(12 Suppl 1):999-1004.
    View in: PubMed
    Score: 0,033
  24. Roles of genetic counselors in South Africa. J Genet Couns. 2013 Dec; 22(6):753-61.
    View in: PubMed
    Score: 0,033
  25. Sirenomelia: four further cases with discussion of associated upper limb defects. Clin Dysmorphol. 2012 Jul; 21(3):124-130.
    View in: PubMed
    Score: 0,031
  26. The utilization and outcome of diagnostic, predictive, and prenatal genetic testing for huntington disease in johannesburg, South Africa. Genet Test Mol Biomarkers. 2012 Jan; 16(1):58-62.
    View in: PubMed
    Score: 0,029
  27. Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population. Pharmacogenomics. 2011 Jul; 12(7):953-63.
    View in: PubMed
    Score: 0,028
  28. Genetic testing for Huntington's disease in South Africa. S Afr Med J. 2008 Mar; 98(3):193-4.
    View in: PubMed
    Score: 0,023
  29. The molecular basis of spinal muscular atrophy (SMA) in South African black patients. Neuromuscul Disord. 2007 Oct; 17(9-10):684-92.
    View in: PubMed
    Score: 0,022
  30. Atypical Presentations of Huntington Disease-like 2 in South African Individuals. Mov Disord Clin Pract. 2024 Jul; 11(7):850-854.
    View in: PubMed
    Score: 0,017
  31. The First Case of Huntington's Disease like 2 in Mali, West Africa. Tremor Other Hyperkinet Mov (N Y). 2024; 14:15.
    View in: PubMed
    Score: 0,017
  32. Mutation profiling in South African patients with Cornelia de Lange syndrome phenotype. Mol Genet Genomic Med. 2024 Jan; 12(1):e2342.
    View in: PubMed
    Score: 0,017
  33. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility. HGG Adv. 2024 Jan 11; 5(1):100244.
    View in: PubMed
    Score: 0,017
  34. Clinical characteristics and one-year all-cause mortality outcomes in Africans with dilated cardiomyopathy. Int J Cardiol. 2023 09 15; 387:131142.
    View in: PubMed
    Score: 0,016
  35. Retrospective file review shows limited genetic services fails most patients - an argument for the implementation of exome sequencing as a first-tier test in resource-constraint settings. Orphanet J Rare Dis. 2023 04 12; 18(1):81.
    View in: PubMed
    Score: 0,016
  36. The genetic basis for adult-onset idiopathic dilated cardiomyopathy in people of African descent. Heart Fail Rev. 2023 Jul; 28(4):879-892.
    View in: PubMed
    Score: 0,016
  37. Increasing African genomic data generation and sharing to resolve rare and undiagnosed diseases in Africa: a call-to-action by the H3Africa rare diseases working group. Orphanet J Rare Dis. 2022 06 16; 17(1):230.
    View in: PubMed
    Score: 0,015
  38. Has translational genomics come of age in Africa? Hum Mol Genet. 2021 10 01; 30(20):R164-R173.
    View in: PubMed
    Score: 0,015
  39. Five years of screening for galactosaemia in South Africa: Pitfalls of using Benedict's test and thin layer chromatography to screen for galactosaemia in a developing country. Clin Chim Acta. 2020 Jun; 505:73-77.
    View in: PubMed
    Score: 0,013
  40. Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis. Clin Pharmacol Ther. 2020 06; 107(6):1420-1433.
    View in: PubMed
    Score: 0,013
  41. The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease. J Huntingtons Dis. 2020; 9(4):325-334.
    View in: PubMed
    Score: 0,013
  42. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease. Am J Hum Genet. 2019 12 05; 105(6):1112-1125.
    View in: PubMed
    Score: 0,013
  43. Different molecular basis for spinal muscular atrophy in South African black patients. Am J Med Genet. 1999 Oct 29; 86(5):420-6.
    View in: PubMed
    Score: 0,013
  44. Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry. Neuroimage Clin. 2019; 21:101666.
    View in: PubMed
    Score: 0,012
  45. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service. J Neuromuscul Dis. 2019; 6(2):241-258.
    View in: PubMed
    Score: 0,012
  46. A recurrent mutation causing Melnick-Needles syndrome in females confers a severe, lethal phenotype in males. Am J Med Genet A. 2018 04; 176(4):980-984.
    View in: PubMed
    Score: 0,011
  47. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. Am J Med Genet B Neuropsychiatr Genet. 2018 04; 177(3):346-357.
    View in: PubMed
    Score: 0,011
  48. Feasibility of prenatal diagnosis and carrier detection in South African haemophilia A patients. Br J Haematol. 1997 Jun; 97(3):558-60.
    View in: PubMed
    Score: 0,011
  49. The Frequency of Huntington Disease and Huntington Disease-Like 2 in the South African Population. Neuroepidemiology. 2016; 46(3):198-202.
    View in: PubMed
    Score: 0,010
  50. Implications of direct-to-consumer whole-exome sequencing in South Africa. S Afr Med J. 2016 Jan 12; 106(2):139-40.
    View in: PubMed
    Score: 0,010
  51. Uptake of Genetic Counseling, Knowledge of Bleeding risks and Psychosocial Impact in a South African Cohort of Female Relatives of People with Hemophilia. J Genet Couns. 2015 Dec; 24(6):978-86.
    View in: PubMed
    Score: 0,009
  52. Clinical and genetic characterization of a founder PKHD1 mutation in Afrikaners with ARPKD. Pediatr Nephrol. 2015 Feb; 30(2):273-9.
    View in: PubMed
    Score: 0,009
  53. New insights into genotype-phenotype correlation for GLI3 mutations. Eur J Hum Genet. 2015 Jan; 23(1):92-102.
    View in: PubMed
    Score: 0,009
  54. Neural tube defects in Gauteng, South Africa: recurrence risks and associated factors. S Afr Med J. 2013 Sep 17; 103(12 Suppl 1):973-7.
    View in: PubMed
    Score: 0,008
  55. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. Eur J Hum Genet. 2013 Oct; 21(10):1120-7.
    View in: PubMed
    Score: 0,008
  56. Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromes. Eur J Hum Genet. 2012 May; 20(5):584-7.
    View in: PubMed
    Score: 0,007
  57. A common Fanconi anemia mutation in black populations of sub-Saharan Africa. Blood. 2005 May 01; 105(9):3542-4.
    View in: PubMed
    Score: 0,005
  58. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol. 2004 Nov; 56(5):670-4.
    View in: PubMed
    Score: 0,004
  59. The hereditary adult-onset ataxias in South Africa. J Neurol Sci. 2003 Dec 15; 216(1):47-54.
    View in: PubMed
    Score: 0,004
  60. FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet. 2003 Feb; 72(2):478-87.
    View in: PubMed
    Score: 0,004
  61. Huntington's disease confirmed by genetic testing in five African families. Mov Disord. 1998 Jul; 13(4):726-30.
    View in: PubMed
    Score: 0,003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.